We welcome colleagues to submit abstracts and deliver oral or poster presentations at ICCPPH 2025. Oral presentations will be conducted in English, with a duration of 30-40 minutes. 

We are actively contacting new reviewers. To become a speaker, please contact our secretary via email <editor@iccpph.com>

Current Speakers

Dr. Aaron Pollett 

Associate Professor at Mount Sinai Hospital, Sinai Health, Canada, specializing in gastrointestinal and anatomical pathology, cancer genetics, and molecular pathology. With a medical degree from the University of Ottawa, a residency at the University of Toronto, and a fellowship in Gastrointestinal Pathology, he has played a key role in advancing hereditary and tumor molecular genetic testing. As the Provincial Lead for the Pathology & Laboratory Medicine Program at Ontario Health, Cancer Care Ontario, he has contributed to standardizing molecular pathology testing across Ontario. His expertise in pathology informatics and precision medicine bridges clinical innovation with genomic research.

Dr. Aurel Popa-Wagner

Professor in the Department of Psychiatry at the Medical University of Greifswald, Germany, specializing in neuroscience, neuroimaging, and neurodegeneration. His research focuses on brain physiology, neurobiology, and the applications of artificial intelligence in neurological disorders. A widely recognized expert, he has contributed extensively to the field through numerous national and international publications and serves as a reviewer for esteemed scientific journals. With an active role in professional societies and multiple awards for his contributions, Dr. Popa-Wagner’s work bridges clinical psychology, neurophysiology, and advanced imaging techniques to deepen the understanding of brain health and disease.

Dr. Boopathi Balasubramaniam

Researcher at the Iowa Institute for Oral Health Research, University of Iowa, USA, specializing in proteomics and molecular biology. His work focuses on C. elegans as a model organism to study host-pathogen interactions, developmental pathways, and infectious diseases. He has contributed to advancing research in microbial pathogen detection, infectious disease diagnostics, and molecular mechanisms of anterior morphogenesis. With expertise spanning biotechnology, molecular biology, and disease modeling, Dr. Balasubramaniam brings valuable insights into omics-driven approaches in precision medicine and public health.

Dr. Hector Quezada

Biochemist and researcher at the National Institute of Cardiology, Mexico, with expertise in cancer research, biotechnology, and infectious disease studies. His work focuses on proteomics-based approaches, particularly in intercellular protein transfer, anti-virulence strategies, and pathogen inhibition mechanisms. Having conducted research in both Mexico and Belgium, he has experience in scientific project design, team coordination, and mentorship, bridging the gap between academic research and industrial applications. His multidisciplinary expertise makes him a valuable contributor to discussions on biotechnological innovations and precision medicine in public health.